A pilot study into bosentan (Tracleer®) as an immunomodulating agent in patients with Behçet’s disease.
Autor: | van der Houwen, Tim B., van Hagen, P. Martin, Kappen, Jasper. H., Kuijpers, Robert W. A. M., van Daele, Paul L. A., van Dik, Wim A., van Laar, Jan A. M. |
---|---|
Zdroj: | Asian Pacific Journal of Allergy & Immunology; Dec2022, Vol. 40 Issue 4, p435-441, 7p |
Databáze: | Complementary Index |
Externí odkaz: |